GPR55 and cholangiocarcinoma: Similar contradictory results were obtained by a previous study, demonstrating a growth inhibition of cholangiocarcinoma cell line Mz-ChA-1 when GPR55 became activated by AEA, an endocannabinoid that generally acts as an agonist at CB1 or CB2 [26].